183 related articles for article (PubMed ID: 387204)
1. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
[TBL] [Abstract][Full Text] [Related]
2. 5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Coltman C; Bottomley R; Wilson H; Bonnet J; Thigpen T; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1978 Sep; 42(3):1228-33. PubMed ID: 359121
[TBL] [Abstract][Full Text] [Related]
3. Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
Moertel CG; Lavin PT
Cancer Treat Rep; 1979; 63(11-12):1863-9. PubMed ID: 393381
[TBL] [Abstract][Full Text] [Related]
4. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
[TBL] [Abstract][Full Text] [Related]
6. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
8. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
[TBL] [Abstract][Full Text] [Related]
9. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.
Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK
J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.
McCracken JD; Ray P; Heilbrun LK; Vaitkevicius VK; Saiki JH; Rivkin SE; Rossof AH; Moore TN
Cancer; 1980 Oct; 46(7):1518-22. PubMed ID: 6998556
[TBL] [Abstract][Full Text] [Related]
11. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
13. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
[TBL] [Abstract][Full Text] [Related]
15. Sequential and combination chemotherapy of advanced gastric cancer.
Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer: current status of treatment.
Carter SK; Comis RL
J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478
[TBL] [Abstract][Full Text] [Related]
17. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Baker LH; Vaitkevicius VK; Gehan E
Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of advanced gastrointestinal cancer.
Moertel CG
Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy in advanced gastrointestinal malignancy.
Vaughn CB; Brady P; Chinn BJ; Daversa GC; Parzuchowski JS
Oncology; 1980; 37(1):57-61. PubMed ID: 6985729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
